LCTX
Price
$1.08
Change
-$0.02 (-1.82%)
Updated
Sep 4 closing price
Capitalization
273.14M
59 days until earnings call
Intraday BUY SELL Signals
PGEN
Price
$7.10
Change
-$0.04 (-0.56%)
Updated
Sep 4 closing price
Capitalization
2.54B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs PGEN

LCTX vs PGEN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LCTX vs. PGEN commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Buy and PGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2026
Stock price -- (LCTX: $1.08 vs. PGEN: $7.10)
Brand notoriety: LCTX and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 59% vs. PGEN: 47%
Market capitalization -- LCTX: $273.14M vs. PGEN: $2.54B
LCTX [@Biotechnology] is valued at $273.14M. PGEN’s [@Biotechnology] market capitalization is $2.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PGEN is a better buy in the long-term than LCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while PGEN’s TA Score has 2 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 3 bearish.
  • PGEN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than PGEN.

Price Growth

LCTX (@Biotechnology) experienced а -2.70% price change this week, while PGEN (@Biotechnology) price change was +2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

LCTX is expected to report earnings on Nov 05, 2026.

PGEN is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($2.54B) has a higher market cap than LCTX($273M). PGEN YTD gains are higher at: 69.856 vs. LCTX (-35.329). LCTX has higher annual earnings (EBITDA): -26.11M vs. PGEN (-143.84M). LCTX has more cash in the bank: 50.8M vs. PGEN (38.2M). LCTX has less debt than PGEN: LCTX (2.3M) vs PGEN (98.3M). PGEN has higher revenues than LCTX: PGEN (85.7M) vs LCTX (13.1M).
LCTXPGENLCTX / PGEN
Capitalization273M2.54B11%
EBITDA-26.11M-143.84M18%
Gain YTD-35.32969.856-51%
P/E RatioN/AN/A-
Revenue13.1M85.7M15%
Total Cash50.8M38.2M133%
Total Debt2.3M98.3M2%
FUNDAMENTALS RATINGS
LCTX vs PGEN: Fundamental Ratings
LCTX
PGEN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
7635
P/E GROWTH RATING
1..100
53100
SEASONALITY SCORE
1..100
244

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (52) in the null industry is in the same range as PGEN (79). This means that LCTX’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's Profit vs Risk Rating (82) in the null industry is in the same range as LCTX (100). This means that PGEN’s stock grew similarly to LCTX’s over the last 12 months.

LCTX's SMR Rating (98) in the null industry is in the same range as PGEN (100). This means that LCTX’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's Price Growth Rating (35) in the null industry is somewhat better than the same rating for LCTX (76). This means that PGEN’s stock grew somewhat faster than LCTX’s over the last 12 months.

LCTX's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for PGEN (100). This means that LCTX’s stock grew somewhat faster than PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXPGEN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
PGEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGOAX8.990.02
+0.22%
Victory Mid-Cap Core Growth A
FGDDX51.320.09
+0.18%
Fidelity Advisor® Dividend Growth A
MLCPX10.43N/A
N/A
MainGate MLP C
IEDBX13.09-0.06
-0.46%
Voya Large Cap Value R2
ALMRX30.15-0.15
-0.50%
Alger Mid Cap Growth Institutional I

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-1.82%
MDGL - LCTX
43%
Loosely correlated
-0.28%
NKTX - LCTX
40%
Loosely correlated
+4.66%
FHTX - LCTX
39%
Loosely correlated
+1.03%
EDIT - LCTX
39%
Loosely correlated
+4.87%
MGX - LCTX
39%
Loosely correlated
+0.86%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with ARRY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-0.56%
ARRY - PGEN
39%
Loosely correlated
+1.32%
VCYT - PGEN
39%
Loosely correlated
-4.79%
AXON - PGEN
38%
Loosely correlated
-4.18%
LCTX - PGEN
38%
Loosely correlated
-1.82%
VKTX - PGEN
36%
Loosely correlated
+2.62%
More